Structural Heart/Valve Disease Program Team

• Heart Valve Disease (Valvular Heart Disease)
  • Aortic stenosis and regurgitation
  • Mitral stenosis and regurgitation
  • Tricuspid regurgitation
  • Pulmonary regurgitation
  • Paravalvular leak
• Stroke Risk Reduction for Atrial Fibrillation (Afib)
  • Percutaneous and surgical left atrial appendage closure
• Septal Defects ("hole in the heart")
  • Congenital/Present at Birth
    - Atrial septal defect (ASD)
    - Ventricular septal defects (VSD)
  • Patent foramen ovale (PFO) closure
• Heart Murmur

Inova is a national leader in minimally invasive repair techniques, including transcatheter aortic valve replacement (TAVR) procedures. Our comprehensive approach identifies the best treatment for each patient.

We offer:

• Outcomes exceeding the national average
• Clinical trials to expand the use of TAVR, including asymptomatic patients and bicuspid aortic valve patients
• A state-of-the-art hybrid operating room where cardiac surgeons, cardiologists and electrophysiologists operate together for fewer complications and shorter recovery
• Expedited referral-to-OR process
• Easily access - just 10 miles from downtown Washington, DC